SynthesisEuropean journal of nutrition2025
Association between leafy vegetable consumption and incidence of metabolic syndrome and its symptoms: a systematic review of prospective cohort and randomised control trials.
Synthesis in European journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Green Leafy Vegetables (GLVs) as Nutritional and Preventive Agents Supporting Metabolism.Metabolites · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeMetabolic syndrome (MetS) is a combination of cardiometabolic risk factors that burden health systems worldwide. Vegetables contain substances that are essential in preventing chronic illnesses. However, the effect of leafy vegetable consumption on the incidence of MetS and its symptoms is unclear. We systematically reviewed the association between leafy vegetable consumption and the incidence of MetS and its symptoms.
methodsThe Web of Science, Scopus, and MEDLINE databases were searched for relevant publications until August 2023. Randomised control trials (RCT) and prospective cohort studies examining the effect of consumption of leafy vegetable/s on MetS or its components in healthy adults were included.
resultsTen studies (eight RCTs and two cohort studies) were included. A reduction in systolic blood pressure after intervention with leafy vegetables was observed in one RCT, but no effect on blood pressure was reported in two RCTs. One cohort study reported reduced hypertension incidence with increased leafy vegetable intake. A reduction in blood glucose was observed in three RCTs, and two RCT found no change. One cohort study reported no association between leafy vegetable consumption and the incidence of type 2 diabetes. Two RCTs found no change in blood lipids. No trials assessing leafy vegetable consumption and obesity or MetS were found.
conclusionFew studies evaluate the impact of leafy vegetable consumption on MetS and its symptoms. Beneficial effects are reported for blood glucose and blood pressure regulation, but the evidence is limited. More studies are needed to build a robust body of evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.